Tumors

Oncology

578 drugs in development·228 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
afinitor	Novartis AG (NVS)
CABOMETYX	EXELIXIS, INC. (EXEL)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
everolimus	Mylan II B.V. (MYL)
GilvetMab	Merck & Co., Inc. (MRK)
lorbrena	PFIZER INC (PFE)
lymphoseek kit	Cardinal Health Inc. (CAH)
nadofaragene firadenovec	CG Oncology, Inc. (CGON)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
pedmark	FENNEC PHARMACEUTICALS INC. (FENC)
sonalleve	Profound Medical Corp. (PROF)
tevimbra	BeOne Medicines Ltd. (ONC)
tykerb	Novartis AG (NVS)
Welireg	Merck & Co., Inc. (MRK)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(72)

Drug	Company
177lu-pnt2003	POINT Biopharma Global Inc. (PNT)
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Alectinib	ENANTA PHARMACEUTICALS INC (ENTA)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
avelumab	GH Research PLC (GHRS)
Avelumab	Merus N.V. (MRUS)
Avelumab	Merck & Co., Inc. (MRK)
azd3470	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
brenetafusp	Immunocore Holdings plc (IMCR)
Brenetafusp and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and kinase inhibitors	Immunocore Holdings plc (IMCR)
Brenetafusp and monoclonal antibodies and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and tebentafusp	Immunocore Holdings plc (IMCR)
Cetuximab	BRISTOL MYERS SQUIBB CO (BMY)
cgt9486	Cogent Biosciences, Inc. (COGT)
Chemotherapy	BeOne Medicines Ltd. (ONC)
Chemotherapy	ARS Pharmaceuticals, Inc. (SPRY)
Divarasib	ENANTA PHARMACEUTICALS INC (ENTA)
eltanexor	Karyopharm Therapeutics Inc. (KPTI)
Entrectinib	ENANTA PHARMACEUTICALS INC (ENTA)
FLOT	AGENUS INC (AGEN)
hmpl-a251	HUTCHMED (China) Ltd (HMDCF)
hmpl-a580	HUTCHMED (China) Ltd (HMDCF)
hmpl-a83	HUTCHMED (China) Ltd (HMDCF)
horse anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
HS-20117 combined HS-20093 and 5-FU	IGM Biosciences, Inc. (IGMS)
HS-20117 combined Platinum-containing chemotherapy	IGM Biosciences, Inc. (IGMS)
HS-20117+FOLFIRI	IGM Biosciences, Inc. (IGMS)
HS-20117+mFOLFOX6	IGM Biosciences, Inc. (IGMS)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
IV Rilvegostomig	ASTRAZENECA PLC (AZN)
JDQ443	Novartis AG (NVS)
Lartesertib	Merck & Co., Inc. (MRK)
Lazertinib	ENANTA PHARMACEUTICALS INC (ENTA)
lutetium[177lu] oxodotreotide	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
MEDI4736	ASTRAZENECA PLC (AZN)
MK-0472	Merck & Co., Inc. (MRK)
MK-1084	Merck & Co., Inc. (MRK)
MK-3120	Merck & Co., Inc. (MRK)
MK-4280	Merck & Co., Inc. (MRK)
MK-4280	Merus N.V. (MRUS)
MK-4280A	Merus N.V. (MRUS)
MK-4280A	Merck & Co., Inc. (MRK)
octreotide lar	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
Other Combination Anti-Cancer Therapies	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
pertuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
Pertuzumab IV	ENANTA PHARMACEUTICALS INC (ENTA)
pnt2003	POINT Biopharma Global Inc. (PNT)
premedication	Genmab A/S (GMAB)
SC Rilvegostomig	ASTRAZENECA PLC (AZN)
SC rilvegostomig + rHu	ASTRAZENECA PLC (AZN)
selumetinib	GH Research PLC (GHRS)
surzebiclimab	BeOne Medicines Ltd. (ONC)
tak-102	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-103	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-188	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-505	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tebentafusp	Immunocore Holdings plc (IMCR)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)
Temozolomide	BRISTOL MYERS SQUIBB CO (BMY)
tev-56278	Teva Pharmaceutical Industries Limited (TEVA)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
tln-372 in combination with cetuximab	IGM Biosciences, Inc. (IGMS)
tsr-042	TESARO, Inc. (TSRO)

Phase 2(70)

Drug	Company
agen2373	AGENUS INC (AGEN)
Aldesleukin	Twist Bioscience Corp (TWST)
alks 4230	Mural Oncology plc (MURA)
Amivantamab	ENANTA PHARMACEUTICALS INC (ENTA)
apl-101	Apollomics Inc. (APLM)
Belvarafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
BMS-986249	CytomX Therapeutics, Inc. (CTMX)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
Camonsertib	ENANTA PHARMACEUTICALS INC (ENTA)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
carbon nanoparticle iron	NYMOX PHARMACEUTICAL CORP (NYMXF)
Cediranib	ADMA BIOLOGICS, INC. (ADMA)
Cediranib	Merus N.V. (MRUS)
Cediranib	ASTRAZENECA PLC (AZN)
chemotherapy	SPECTRUM PHARMACEUTICALS INC (SPPI)
crolibulin	IMMUNE PHARMACEUTICALS INC (IMNP)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
daraxonrasib	BRISTOL MYERS SQUIBB CO (BMY)
Direct Oral Anticoagulant	Structure Therapeutics Inc. (GPCR)
eflapegrastim	SPECTRUM PHARMACEUTICALS INC (SPPI)
Eflapegrastim	ARS Pharmaceuticals, Inc. (SPRY)
eganelisib	INFINITY PHARMACEUTICALS, INC. (INFI)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
exosting	Codiak BioSciences, Inc. (CDAK)
Fludarabine	Twist Bioscience Corp (TWST)
fpi-2059	Fusion Pharmaceuticals Inc. (FUSN)
fyarro	Whitehawk Therapeutics, Inc. (WHWK)
gen-009	GENOCEA BIOSCIENCES, INC. (GNCA)
gomekli	SpringWorks Therapeutics, Inc. (SWTX)
IMP321	Immutep Limited (IMMP)
imx-110	Immix Biopharma, Inc. (IMMX)
Individual Patient TCR-Transduced PBL	Twist Bioscience Corp (TWST)
infigratinib	LianBio (LIANY)
Interleukin-2	Filana Therapeutics Inc. (FLNA)
jdq443	Novartis AG (NVS)
jtx-8064	Jounce Therapeutics, Inc. (JNCE)
kb-0742	Kronos Bio, Inc. (KRON)
Lenvatinib	Merus N.V. (MRUS)
leucovorin	Mirati Therapeutics, Inc. (MRTX)
Leucovorin	FATE THERAPEUTICS INC (FATE)
methionine	GH Research PLC (GHRS)
Mivavotinib (CB-659)	Calithera Biosciences, Inc. (CALA)
mm-121	MERRIMACK PHARMACEUTICALS INC (MACK)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
nazartinib	Novartis AG (NVS)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
osimertinib	Novartis AG (NVS)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
Pemetrexed	FATE THERAPEUTICS INC (FATE)
Pemetrexed	Structure Therapeutics Inc. (GPCR)
poziotinib	Assertio Holdings, Inc. (ASRT)
Pralsetinib	ENANTA PHARMACEUTICALS INC (ENTA)
rad101	Radiopharm Theranostics Limited (RADX)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
seribantumab	Elevation Oncology, Inc. (ELEV)
snk02	NKGen Biotech, Inc. (NKGN)
solnerstotug	Sensei Biotherapeutics, Inc. (SNSE)
sotigalimab	Apexigen, Inc. (APGN)
SRK-181	Scholar Rock Holding Corp (SRRK)
tislelizumab	Novartis AG (NVS)
tislelizumab	Novartis AG (NVS)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
Tuvusertib	Merck & Co., Inc. (MRK)
vir-5818	Vir Biotechnology, Inc. (VIR)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)

Phase 1(222)

Drug	Company
[14c] subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
[14c] subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
177lu-pnt6555	POINT Biopharma Global Inc. (PNT)
a small molecular multi-target kinase inhibitor	UNITED THERAPEUTICS Corp (UTHR)
AB521	EXELIXIS, INC. (EXEL)
ABBV-181	AbbVie Inc. (ABBV)
ABBV-368	AbbVie Inc. (ABBV)
ABBV-711	AbbVie Inc. (ABBV)
Abiraterone	BioNTech SE (BNTX)
abtl-0812	SCICLONE PHARMACEUTICALS INC (SCLN)
ACR-2316	Acrivon Therapeutics, Inc. (ACRV)
adagrasib	Incyte Corp. (INCY)
adxs-her2	OLD AYALA, INC (AYLA)
ADXS-HER2 (ADXS31-164)	Ayala Pharmaceuticals, Inc. (ADXS)
amg 355	AMGEN INC (AMGN)
amg 410	AMGEN INC (AMGN)
amg 436	AMGEN INC (AMGN)
amg 510	AMGEN INC (AMGN)
an9025	Adlai Nortye Ltd. (ANL)
Anti-PD-1 monoclonal antibody	iTeos Therapeutics, Inc. (ITOS)
anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
Anticancer agent	iTeos Therapeutics, Inc. (ITOS)
anvumetostat	AMGEN INC (AMGN)
APR-1051	Aprea Therapeutics, Inc. (APRE)
arq 751	ARQULE INC (ARQL)
ASP1570	IGM Biosciences, Inc. (IGMS)
atrc-101	Atreca, Inc. (BCEL)
ATRN-119	Aprea Therapeutics, Inc. (APRE)
aube00	CASI Pharmaceuticals, Inc (DE) (CASI)
AUTO6NG	Autolus Therapeutics plc (AUTL)
Avelumab	Immutep Limited (IMMP)
bg-89894	BeOne Medicines Ltd. (ONC)
BG-89894	BeOne Medicines Ltd. (ONC)
bg-c0902	BeOne Medicines Ltd. (ONC)
BG-C0902	BeOne Medicines Ltd. (ONC)
bg-c477	BeOne Medicines Ltd. (ONC)
BG-C477	BeOne Medicines Ltd. (ONC)
BG-C477	Merus N.V. (MRUS)
BGB-53038	ENANTA PHARMACEUTICALS INC (ENTA)
BGB-53038	BeOne Medicines Ltd. (ONC)
BGB-B455	Merus N.V. (MRUS)
bgm-2121	PRECISION BIOSCIENCES INC (DTIL)
BI 1831169	ENANTA PHARMACEUTICALS INC (ENTA)
bi-1206	CASI Pharmaceuticals, Inc (DE) (CASI)
bms-986258	FIVE PRIME THERAPEUTICS, INC. (FPRX)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
BT1718	BICYCLE THERAPEUTICS PLC (BCYC)
cabozantinib	Kura Oncology, Inc. (KURA)
Calcium folinate	BRISTOL MYERS SQUIBB CO (BMY)
CAN-3110	Candel Therapeutics, Inc. (CADL)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
cetuximab	Erasca, Inc. (ERAS)
cetuximab	Incyte Corp. (INCY)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
cetuximab	CASI Pharmaceuticals, Inc (DE) (CASI)
cetuximab	C4 Therapeutics, Inc. (CCCC)
Cetuximab	BeOne Medicines Ltd. (ONC)
CFT1946	C4 Therapeutics, Inc. (CCCC)
chemotherapy	BeOne Medicines Ltd. (ONC)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
CLR 121225	Cellectar Biosciences, Inc. (CLRB)
cna3103	Neuphoria Therapeutics Inc. (NEUP)
CT-0508	Carisma Therapeutics Inc. (CARM)
CT-0525	Carisma Therapeutics Inc. (CARM)
CT-1119	Carisma Therapeutics Inc. (CARM)
CT-202	Context Therapeutics Inc. (CNTX)
CT-95	Context Therapeutics Inc. (CNTX)
CX-904	CytomX Therapeutics, Inc. (CTMX)
darlifarnib	Kura Oncology, Inc. (KURA)
day301	Day One Biopharmaceuticals, Inc. (DAWN)
DB-1311	KYNTRA BIO INC. (KYNB)
dcr-pdl1	Dicerna Pharmaceuticals Inc (DRNA)
dcvax-direct	NORTHWEST BIOTHERAPEUTICS INC (NWBO)
DS6051b	Nuvation Bio Inc. (NUVB)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elzovantinib	Turning Point Therapeutics, Inc. (TPTX)
Enzalutamide	BioNTech SE (BNTX)
EO-3021	Elevation Oncology, Inc. (ELEV)
EO-3021 (also known as SYSA1801 or CPO102)	Elevation Oncology, Inc. (ELEV)
EOS006215	iTeos Therapeutics, Inc. (ITOS)
EOS301984	iTeos Therapeutics, Inc. (ITOS)
epacadostat	Incyte Corp. (INCY)
ERAS-0015	Erasca, Inc. (ERAS)
ERAS-0015 in combination	Erasca, Inc. (ERAS)
ERAS-4001	Erasca, Inc. (ERAS)
ERAS-4001 in combination	Erasca, Inc. (ERAS)
ERAS-601	Erasca, Inc. (ERAS)
etigilimab	OncoMed Pharmaceuticals Inc (OMED)
felezonexor	STEMLINE THERAPEUTICS INC (STML)
FID-022	Fulgent Genetics Inc. (FLGT)
folfiri	Incyte Corp. (INCY)
folfox	Incyte Corp. (INCY)
fpi-1966	Fusion Pharmaceuticals Inc. (FUSN)
fpt155	FIVE PRIME THERAPEUTICS, INC. (FPRX)
gemnabp	Incyte Corp. (INCY)
gl-onc1	GENELUX Corp (GNLX)
gs-1811	Jounce Therapeutics, Inc. (JNCE)
gs-2121	GILEAD SCIENCES, INC. (GILD)
gs-9911	GILEAD SCIENCES, INC. (GILD)
hbm4003	Q BioMed Inc. (QBIO)
hemopurifier	Aethlon Medical Inc. (AEMD)
hro761	NOVARTIS AG (NVSEF)
hro761	Novartis AG (NVS)
HS-20117 combined HS-20093	IGM Biosciences, Inc. (IGMS)
HS-20117+CAPEOX	IGM Biosciences, Inc. (IGMS)
IDE275 (GSK959)	IDEAYA Biosciences, Inc. (IDYA)
IDE705 (GSK101)	IDEAYA Biosciences, Inc. (IDYA)
im-1340	Immunome Inc. (IMNM)
im-3050	Immunome Inc. (IMNM)
IMC-R117C (PIWIL-1)	Immunocore Holdings plc (IMCR)
imgc936	ImmunoGen, Inc. (IMGN)
IMGC936	MACROGENICS INC (MGNX)
IMP321	Merus N.V. (MRUS)
inca00186	Incyte Corp. (INCY)
inca036873	Incyte Corp. (INCY)
inca33890	Incyte Corp. (INCY)
incb0123667	Incyte Corp. (INCY)
incb057643	Incyte Corp. (INCY)
incb059872	Incyte Corp. (INCY)
incb081776	Incyte Corp. (INCY)
incb086550	Incyte Corp. (INCY)
incb099280	Incyte Corp. (INCY)
incb099318	Incyte Corp. (INCY)
incb106385	Incyte Corp. (INCY)
incb161734	Incyte Corp. (INCY)
incb186748	Incyte Corp. (INCY)
incmga00012	Incyte Corp. (INCY)
Interleukin-2	Merus N.V. (MRUS)
iph4502	Innate Pharma S.A. (IPHA)
itraconazole	KYNTRA BIO INC. (KYNB)
kin-2787	KINNATE BIOPHARMA INC. (KNTE)
KSQ-001EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	Merus N.V. (MRUS)
KSQ-004EX	Filana Therapeutics Inc. (FLNA)
KSQ-004EX	ENANTA PHARMACEUTICALS INC (ENTA)
KT-253	Kymera Therapeutics, Inc. (KYMR)
KT-333	Kymera Therapeutics, Inc. (KYMR)
Lopinavir and Ritonavir Tablets	BioNTech SE (BNTX)
loxo-292	LOXO ONCOLOGY, INC. (LOXO)
m7437	GH Research PLC (GHRS)
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	Fortress Biotech Inc. (FBIO)
mfolfirinox	Incyte Corp. (INCY)
MGC028	MACROGENICS INC (MGNX)
MK-1484	SUTRO BIOPHARMA, INC. (STRO)
mnpr-101-lu	Monopar Therapeutics (MNPR)
mnpr-101-zr	Monopar Therapeutics (MNPR)
MRG007	ArriVent BioPharma, Inc. (AVBP)
mRNA-4157	Moderna, Inc. (MRNA)
MT-304	ENANTA PHARMACEUTICALS INC (ENTA)
mt-6402	Molecular Templates, Inc. (MTEM)
nana-val	Viracta Therapeutics, Inc. (VIRX)
Naporafenib	Erasca, Inc. (ERAS)
narazaciclib	TRAWS PHARMA, INC. (ONTX)
ngm438	NGM BIOPHARMACEUTICALS INC (NGM)
ngm831	NGM BIOPHARMACEUTICALS INC (NGM)
NK Cell Infusion	Filana Therapeutics Inc. (FLNA)
NT-I7	Merck & Co., Inc. (MRK)
NUV-868	KYNTRA BIO INC. (KYNB)
onc206	CHIMERIX INC (CMRX)
oncr-177	Oncorus, Inc. (ONCR)
panitumumab	AMGEN INC (AMGN)
pelcitoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
pf-8046052	LAVA Therapeutics NV (LVTX)
pimivalimab	Jounce Therapeutics, Inc. (JNCE)
PLN-101095	PLIANT THERAPEUTICS, INC. (PLRX)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
prn1371	Principia Biopharma Inc. (PRNB)
promitil	Rafael Holdings, Inc. (RFL)
pt-112	SCICLONE PHARMACEUTICALS INC (SCLN)
qtx3034	QUANTA INC (QNTA)
qtx3544	QUANTA INC (QNTA)
Recombinant Human Hyaluronidase	ASTRAZENECA PLC (AZN)
retifanlimab	Incyte Corp. (INCY)
rhIL-15	Filana Therapeutics Inc. (FLNA)
rmc-5552	REVOLUTION MEDICINES, INC. (RVMD)
RP-6306	IGM Biosciences, Inc. (IGMS)
rxdx-105	Ignyta, Inc. (RXDX)
S095035	Tango Therapeutics, Inc. (TNGX)
sibp-a10	CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (CBPO)
sim0505	NextCure, Inc. (NXTC)
sl-801	STEMLINE THERAPEUTICS INC (STML)
sl-901	STEMLINE THERAPEUTICS INC (STML)
sqz-aac-hpv	SQZ Biotechnologies Co (SQZB)
sqz-pbmc-hpv	SQZ Biotechnologies Co (SQZB)
ST101	Merus N.V. (MRUS)
ST101	Myovant Sciences Ltd. (MYOV)
ST101	Royalty Pharma plc (RPRX)
ST101	Janux Therapeutics, Inc. (JANX)
ST101	PTC THERAPEUTICS, INC. (PTCT)
subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
sy-5609	Syros Pharmaceuticals, Inc. (SYRS)
TAK-188	Merus N.V. (MRUS)
taladegib	Ignyta, Inc. (RXDX)
tbs-2025	TuHURA Biosciences, Inc./NV (HURA)
tcellvax	Regen BioPharma Inc (RGBPP)
tcrt-eso-a2	Athenex, Inc. (ATNX)
Temozolomide	Myovant Sciences Ltd. (MYOV)
Temozolomide	Royalty Pharma plc (RPRX)
Temozolomide	Janux Therapeutics, Inc. (JANX)
Tilsotolimod	AbbVie Inc. (ABBV)
tislelizumab	Q BioMed Inc. (QBIO)
tln-372	IGM Biosciences, Inc. (IGMS)
tno155	Novartis AG (NVS)
toripalimab	Q BioMed Inc. (QBIO)
tpx-0046	Turning Point Therapeutics, Inc. (TPTX)
trametinib	C4 Therapeutics, Inc. (CCCC)
Trametinib	Erasca, Inc. (ERAS)
treatment of mnc-168 enteric-coated capsules as a single	Curative Biotechnology Inc (CUBT)
Trifluridine + Tipiracil	IGM Biosciences, Inc. (IGMS)
tsr-022	TESARO, Inc. (TSRO)
wtx-712	Werewolf Therapeutics, Inc. (HOWL)
XB010	EXELIXIS, INC. (EXEL)
XB371	EXELIXIS, INC. (EXEL)
XL309	EXELIXIS, INC. (EXEL)
XmAb808	Xencor Inc (XNCR)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
zl-1310	Zai Lab Ltd (ZLAB)
zl-6201	Zai Lab Ltd (ZLAB)
zw191	Zymeworks Inc. (ZYME)

Preclinical(96)

Drug	Company
244c8	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
388d4	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
Aarvik ADC program	ArriVent BioPharma, Inc. (AVBP)
adp-520	Adaptimmune Therapeutics PLC (ADAP)
adp-600	Adaptimmune Therapeutics PLC (ADAP)
aktx-101	Akari Therapeutics Plc (AKTX)
Allogeneic CAR T cell therapy	Intellia Therapeutics, Inc. (NTLA)
allogeneic mait cell therapy	Pluri Inc. (PLUR)
Alpha-201 Macro1	Candel Therapeutics, Inc. (CADL)
Alpha-beta T-cell therapies for cancer	Editas Medicine, Inc. (EDIT)
Antibody drug conjugate (ADC) candidates	Fulgent Genetics Inc. (FLGT)
apkci inhibitor	WINDTREE THERAPEUTICS INC /DE/ (WINT)
apn-346958	Atreca, Inc. (BCEL)
apn-497444	Atreca, Inc. (BCEL)
apvo451	Aptevo Therapeutics Inc. (APVO)
apvo603	Aptevo Therapeutics Inc. (APVO)
ba3142	BioAtla, Inc. (BCAB)
ba3361	BioAtla, Inc. (BCAB)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
cab-nectin 4 x cab-cd3	BioAtla, Inc. (BCAB)
CB-668	Calithera Biosciences, Inc. (CALA)
CBO421	Cidara Therapeutics, Inc. (CDTX)
cf33 oncolytic virus therapy	RenovoRx, Inc. (RNXT)
chs-1000	Coherus Oncology, Inc. (CHRS)
CLD-400 (RTNova)	Calidi Biotherapeutics Inc. (CLDI)
CPI-935	Corvus Pharmaceuticals, Inc. (CRVS)
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
diffronc	Regen BioPharma Inc (RGBPP)
dnase-armored car t	Xenetic Biosciences, Inc. (XBIO)
duracar	Regen BioPharma Inc (RGBPP)
enLIGHTEN™ Discovery Platform (platform-level entry)	Candel Therapeutics, Inc. (CADL)
EO-1022	Elevation Oncology, Inc. (ELEV)
fpa157	FIVE PRIME THERAPEUTICS, INC. (FPRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
GPC3-targeted CAR T	CRISPR Therapeutics AG (CRSP)
gsk4381562	Coherus Oncology, Inc. (CHRS)
gtb-5550	GT Biopharma, Inc. (GTBP)
hcw11-018b	HCW Biologics Inc. (HCWB)
HER3-ADC (unnominated)	Elevation Oncology, Inc. (ELEV)
ifabotuzumab	HUMANIGEN, INC (HGEN)
im-1335	Immunome Inc. (IMNM)
inb-300	IN8BIO, INC. (INAB)
inb-600	IN8BIO, INC. (INAB)
io112	IO Biotech, Inc. (IOBT)
io170	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
jtx-1484	Jounce Therapeutics, Inc. (JNCE)
jtx-2134	Jounce Therapeutics, Inc. (JNCE)
kros 301	Kairos Pharma, LTD. (KAPA)
kva12123	TuHURA Biosciences, Inc./NV (HURA)
ladr 10	LadRx Corp (LADX)
ladr 7	LadRx Corp (LADX)
ladr 8	LadRx Corp (LADX)
ladr 9	LadRx Corp (LADX)
ladr-10	LadRx Corp (LADX)
ladr-7	LadRx Corp (LADX)
ladr-8	LadRx Corp (LADX)
ladr-9	LadRx Corp (LADX)
ladr10	LadRx Corp (LADX)
ladr7	LadRx Corp (LADX)
ladr8	LadRx Corp (LADX)
ladr9	LadRx Corp (LADX)
linebacker	IMPACT BIOMEDICAL INC. (IBO)
linebacker-1	IMPACT BIOMEDICAL INC. (IBO)
linebacker-2	IMPACT BIOMEDICAL INC. (IBO)
mait cells	Pluri Inc. (PLUR)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
mdvac	Orgenesis Inc. (ORGS)
MGC030	MACROGENICS INC (MGNX)
mm-111	MERRIMACK PHARMACEUTICALS INC (MACK)
mnpr-101-ac	Monopar Therapeutics (MNPR)
Moderna development candidate - GPC3	Carisma Therapeutics Inc. (CARM)
mstar antibody	OPKO HEALTH, INC. (OPK)
neo-ptc-01	Neon Therapeutics, Inc. (NTGN)
neurohub	BRAIN SCIENTIFIC INC. (BRSF)
nexi-005	NexImmune, Inc. (NEXI)
nkx070	Nkarta, Inc. (NKTX)
onc212	CHIMERIX INC (CMRX)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
Pb212-VMT-⍺-NET	Lantheus Holdings, Inc. (LNTH)
pnt2004	POINT Biopharma Global Inc. (PNT)
pop1 program	Propanc Biopharma, Inc. (PPCB)
rad52 inhibitor	Rain Oncology Inc. (RAIN)
rt-ar001	REBUS HOLDINGS, INC. (NSPX)
rxdx-106	Ignyta, Inc. (RXDX)
rxdx-107	Ignyta, Inc. (RXDX)
sgr-3515	Schrodinger, Inc. (SDGR)
SNAP-CAR Platform	Coeptis Therapeutics Holdings Inc. (COEP)
t-loop	Orgenesis Inc. (ORGS)
tetra-specific antibody	OPKO HEALTH, INC. (OPK)
thor-707	Synthorx, Inc. (THOR)
trop2 adc	Peak Bio, Inc. (PKBO)
Undisclosed (Solid Tumors)	FATE THERAPEUTICS INC (FATE)
Unnamed enLIGHTEN™ candidate encoding IL-12 and IL-15	Candel Therapeutics, Inc. (CADL)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Unknown(8)

Drug	Company
CB-020	Caribou Biosciences, Inc. (CRBU)
COMET instrument (Lunaphore)	BIO-TECHNE Corp (TECH)
ecDNA directed therapeutic candidates (ecDTx)	Boundless Bio, Inc. (BOLD)
Granulocyte colony-stimulating factor	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
HER-2 targeting ARC (CD47 combination program)	Actinium Pharmaceuticals, Inc. (ATNM)
HER3 targeting ARC	Actinium Pharmaceuticals, Inc. (ATNM)
HLX14	Organon & Co. (OGN)
Precise Tumor	MYRIAD GENETICS INC (MYGN)

BLA Filed(2)

Drug	Company
larotrectinib	LOXO ONCOLOGY, INC. (LOXO)
PNT2003	Lantheus Holdings, Inc. (LNTH)

N/A(1)

Drug	Company
Pb212-VMT-α-NET	Lantheus Holdings, Inc. (LNTH)

Phase 1/Phase 2(76)

Drug	Company
[203pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
[212pb]vmt-α-net	Perspective Therapeutics, Inc. (CATX)
abiraterone	Incyte Corp. (INCY)
all-trans retinoic acid	Incyte Corp. (INCY)
anti pd-1/l1	AMGEN INC (AMGN)
bemarituzumab	AMGEN INC (AMGN)
blu-222	Blueprint Medicines Corp (BPMC)
bpx-603	BELLICUM PHARMACEUTICALS, INC (BLCM)
brimarafenib	SpringWorks Therapeutics, Inc. (SWTX)
cemiplimab	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cetuximab	Novartis AG (NVS)
cetuximab	AC Immune SA (ACIU)
cetuximab	Mirati Therapeutics, Inc. (MRTX)
chemotherapy	Incyte Corp. (INCY)
chemotherapy	Oric Pharmaceuticals, Inc. (ORIC)
CLN-418	Cullinan Therapeutics, Inc. (CGEM)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
cpi-0209	CONSTELLATION PHARMACEUTICALS INC (CNST)
cr-001	CRESCENT BIOPHARMA, INC. (CBIO)
cr-002	CRESCENT BIOPHARMA, INC. (CBIO)
cr-003	CRESCENT BIOPHARMA, INC. (CBIO)
dcc-3116	Deciphera Pharmaceuticals, Inc. (DCPH)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
envometinib	Immuneering Corp (IMRX)
ERAS-007	Erasca, Inc. (ERAS)
ERAS-12	Erasca, Inc. (ERAS)
ERAS-3490	Erasca, Inc. (ERAS)
ERAS-4	Erasca, Inc. (ERAS)
ERAS-801	Erasca, Inc. (ERAS)
gen1057	GENMAB A/S (GNMSF)
gen1057	Genmab A/S (GMAB)
gen1079	Genmab A/S (GMAB)
gen1079	GENMAB A/S (GNMSF)
gen1106	GENMAB A/S (GNMSF)
gen1106	Genmab A/S (GMAB)
hpn328	Harpoon Therapeutics, Inc. (HARP)
imc-r117c	Immunocore Holdings plc (IMCR)
incb177054	Incyte Corp. (INCY)
iph4502	Innate Pharma SA (IPHYF)
Itraconazole	BioNTech SE (BNTX)
ivonescimab	REVOLUTION MEDICINES, INC. (RVMD)
lee011	Novartis AG (NVS)
LEE011	Novartis AG (NVS)
lp-184	Lantern Pharma Inc. (LTRN)
LY3537982	ELI LILLY & Co (LLY)
m9140	GH Research PLC (GHRS)
mdx2001	OPKO HEALTH, INC. (OPK)
mdx2003	OPKO HEALTH, INC. (OPK)
mfolfox6	AC Immune SA (ACIU)
miransertib	ARQULE INC (ARQL)
monalizumab	AC Immune SA (ACIU)
mRNA-4359	Moderna, Inc. (MRNA)
nc762	NextCure, Inc. (NXTC)
olaparib	Incyte Corp. (INCY)
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)
oric-114	Oric Pharmaceuticals, Inc. (ORIC)
phase 1b	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
platinum-based doublet chemotherapy	VERTEX PHARMACEUTICALS INC / MA (VRTX)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075	VERTEX PHARMACEUTICALS INC / MA (VRTX)
rucaparib	Incyte Corp. (INCY)
slate	Gritstone bio, Inc. (GRTS)
sqz-eapc-hpv	SQZ Biotechnologies Co (SQZB)
tak-188	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-505	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-981	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tc-520	TCR2 THERAPEUTICS INC. (TCRR)
THE-630	Theseus Pharmaceuticals, Inc. (THRX)
tno155	Novartis AG (NVS)
trifluridine-tipiracil	REGENERON PHARMACEUTICALS, INC. (REGN)
trifluridine-tipiracil	VERTEX PHARMACEUTICALS INC / MA (VRTX)
VMT-α-NET	Perspective Therapeutics, Inc. (CATX)
wtx-330	Werewolf Therapeutics, Inc. (HOWL)
XmAb662	Xencor Inc (XNCR)
zoldonrasib	REVOLUTION MEDICINES, INC. (RVMD)

Phase 2/Phase 3(7)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
eik1004	Eikon Therapeutics Inc. (EIKN)
eik1004-001	Eikon Therapeutics Inc. (EIKN)
eik1005	Eikon Therapeutics Inc. (EIKN)
IDE-161	IDEAYA Biosciences, Inc. (IDYA)
surufatinib	HUTCHMED (China) Ltd (HMDCF)
surufatinib	HUTCHMED (China) Limited (HCM)

Phase 4(9)

Drug	Company
axitinib	Incyte Corp. (INCY)
BAT8008 for Injection	Merus N.V. (MRUS)
bms-986484	BRISTOL MYERS SQUIBB CO (BMY)
bms-986488	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
nazartinib	NOVARTIS AG (NVSEF)
osimertinib	NOVARTIS AG (NVSEF)
trametinib	Novartis AG (NVS)
Trametinib	Novartis AG (NVS)

Compare drugs

afinitor vs CABOMETYX afinitor vs carmustine afinitor vs everolimus

Frequently asked questions

How many drugs are in development for Tumors?

BioSniper tracks 578 drugs in development for Tumors across 228 companies.

How many clinical trials target Tumors?

There are 1 clinical trial targeting Tumors tracked by BioSniper.

Deep-dive into Tumors

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis